Global Tuberculosis (TB) Diagnostics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029.Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other parts of the body, such as the kidneys, spine, and brain. TB is spread through the air when an infected person coughs, sneezes, or talks, and others inhale the bacteria.. The Tuberculosis (TB) Diagnostics market is expanding because of factors such as increasing incidence of Tuberculosis, supportive government initiatives and increased Public-Private Partnerships.

The primary driver fueling market expansion is the increase in cases of tuberculosis and multi-drug resistant tuberculosis (MDR-TB). For instance, the World Health Organization’s (WHO) Global Tuberculosis Report 2021 states that in October 2021, the majority of tuberculosis cases were discovered in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while fewer cases were discovered in the Eastern Mediterranean (8.3%), and Europe (2.3%). Additionally, according to statistics released by the World Health Organization (WHO), around 10 million individuals worldwide contracted tuberculosis in 2020, and roughly 1.5 million people died as a result of the disease in October 2021. Therefore, the increased prevalence of tuberculosis among the population drives up the demand for better diagnostic tools and therapies, which is expected to drive market expansion over the forecast period. Furthermore, advent of advanced test methods is creating lucrative growth in the market. However, high cost of tuberculosis (tb) diagnostics and limitations of existing tuberculosis (TB) diagnostics may halt market growth.

The key regions considered for the Global Tuberculosis (TB) Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to factors such as increasing number of cases of tuberculosis in the area, the availability of an advanced healthcare system, and high healthcare spending. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising prevalence of target disease, rising government initiatives, and rising development of new technology.

Major market players included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux SA
Cepheid
F. Hoffmann-La Roche AG
Hain Lifescience GmbH
Hologic Corporation
Qiagen
AdvaCare Pharma
Thermo Fisher Scientific Inc.

Recent Developments in the Market:
In February 2022, SRL Diagnostics announced the launch of a whole genome sequencing test for tuberculosis The test shortens the time needed to identify multi-drug resistant tuberculosis and provides a comprehensive resistance profile to 18 different anti-TB medications.
Thermo Fisher Scientific Inc. introduced the SeqStudio Flex Series Genetic Analyzer, For research and development of infectious disease detection. which is anticipated to broaden the company’s product line in the market.


Global Tuberculosis (TB) Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Diagnostic Test Type, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Diagonistics Test Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Test Type:
Radiographic Test
Laboratory Test
Nucleic Acid Testing
Cytokine Detection Test
Other Diagnostic Test Types

By End-User:
Human Tuberculosis (TB) Diagnostics
Tuberculosis (TB) Diagnostics Analog

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World